TR BioSurgical Commercializes Breakthrough Tissue Repair BioScaffold

 11.07.2008 05:15   medicalnewstoday.com

TR BioSurgical, LLC, a veterinary biomaterials company, announced they have commercialized a breakthrough medical device scaffold called TR Matrix™. TR Matrix consists of collagen that has been engineered into a unique, open polar structure that mimics early stage connective tissue.

World Medical Equipment